We are live on ! Find out more
XK

Xact Kapitalforvaltning Portfolio holdings

AUM $4.7B
1-Year Est. Return 0.05%
This Fund
S&P 500
This Quarter Est. Return
+10.95%
1 Year Est. Return
-0.05%
3 Year Est. Return
+34.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.88B
AUM Growth
+$618M
Cap. Flow
+$106M
Cap. Flow %
1.8%
Top 10 Hldgs %
22.46%
Holding
1,459
New
30
Increased
469
Reduced
96
Closed
51

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$9.68M
2
AMZN icon
Amazon
AMZN
+$6.71M
3
MSFT icon
Microsoft
MSFT
+$5.34M
4
META icon
Meta Platforms (Facebook)
META
+$3.18M
5
CRM icon
Salesforce
CRM
+$2.99M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$17.5M
2
TFC icon
Truist Financial
TFC
+$8.4M
3
STI
SunTrust Banks, Inc.
STI
+$6.79M
4
DOC icon
Healthpeak Properties
DOC
+$4.82M
5
GEN icon
Gen Digital
GEN
+$2.93M

Sector Composition

Rank Sector Weight
1 Technology 23.11%
2 Financials 15.93%
3 Healthcare 15.67%
4 Consumer Discretionary 12.39%
5 Communication Services 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBOC icon
1226
International Bancshares
IBOC
$4.57B
$314K 0.01%
7,302
– –
PPBI
1227
DELISTED
Pacific Premier Bancorp
PPBI
$314K 0.01%
9,623
– –
PIPR icon
1228
Piper Sandler
PIPR
$5.29B
$310K 0.01%
15,488
– –
PCRX icon
1229
Pacira BioSciences
PCRX
$997M
$309K 0.01%
6,823
– –
PDCO
1230
DELISTED
Patterson Companies, Inc.
PDCO
$309K 0.01%
15,100
– –
WSFS icon
1231
WSFS Financial
WSFS
$4.15B
$308K 0.01%
7,005
– –
RPT
1232
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$307K 0.01%
20,397
– –
HRTX icon
1233
Heron Therapeutics
HRTX
$92.9M
$306K 0.01%
13,000
– –
TRMK icon
1234
Trustmark
TRMK
$2.75B
$306K 0.01%
8,860
– –
BEAT
1235
DELISTED
BioTelemetry, Inc.
BEAT
$306K 0.01%
6,600
– –
ALLO icon
1236
Allogene Therapeutics
ALLO
$694M
$304K 0.01%
+11,700
New +$322K
CNS icon
1237
Cohen & Steers
CNS
$4.3B
$304K 0.01%
4,851
– –
ECHO
1238
EchoStar
ECHO
$26.2B
$300K 0.01%
6,916
– –
LBAI
1239
DELISTED
Lakeland Bancorp Inc
LBAI
$300K 0.01%
17,253
– –
HCSG icon
1240
Healthcare Services Group
HCSG
$1.53B
$299K 0.01%
12,295
– –
WERN icon
1241
Werner Enterprises
WERN
$2.25B
$299K 0.01%
8,230
– –
WSBC icon
1242
WesBanco
WSBC
$4B
$299K 0.01%
7,909
– –
MSTR icon
1243
Strategy Inc
MSTR
$38.4B
$298K 0.01%
20,860
– –
PZZA icon
1244
Papa John's
PZZA
$806M
$294K 0.01%
4,651
– –
BPFH
1245
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$294K 0.01%
24,420
– –
LZB icon
1246
La-Z-Boy
LZB
$1.69B
$293K 0.01%
9,302
– –
PRK icon
1247
Park National Corp
PRK
$3.67B
$293K 0.01%
2,865
– –
PS
1248
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$293K 0.01%
17,000
– –
PRGS icon
1249
Progress Software
PRGS
$1.76B
$292K 0.01%
7,016
– –
RGNX icon
1250
Regenxbio
RGNX
$708M
$291K ﹤0.01%
7,100
– –
48 49
50
51 52

Similar funds

HFA
Harvest Fund Advisors Wayne, Pennsylvania $4.87B AUM 49.03% 1-Year Est. Return
BPSG
Brookfield Public Securities Group New York $6.17B AUM
PIA
Piedmont Investment Advisors Durham, North Carolina $2.53B AUM 0.83% 1-Year Est. Return
FTIOP
Fiduciary Trust International of Pennsylvania Radnor, Pennsylvania $2.14B AUM 3.72% 1-Year Est. Return
CEP
Chicago Equity Partners Chicago, Illinois $993M AUM 6.42% 1-Year Est. Return
EA
Echinus Advisors New York $881M AUM 6.76% 1-Year Est. Return
OWD
Osborn Williams & Donohoe Cincinnati, Ohio $762M AUM 2.74% 1-Year Est. Return
AVC
Arlington Value Capital Salt Lake City, Utah $688M AUM 23.52% 1-Year Est. Return

Xact Kapitalforvaltning's Q4 2019 Portfolio in Review

As of Q4 2019, Xact Kapitalforvaltning held 1,459 positions worth $5.88B, up 12% from $5.26B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Xact Kapitalforvaltning's Q4 2019 filing shows 30 new, 469 increased, 96 reduced and 51 closed positions. Its largest new stake was BeOne Medicines Ltd: 11,100 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Xact Kapitalforvaltning's largest Q4 2019 buy was BeOne Medicines Ltd: 11,100 shares worth $1.84M.
  • Xact Kapitalforvaltning added most to Alibaba in Q4 2019, an estimated $9.68M increase.
  • Xact Kapitalforvaltning's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.28M.
  • Xact Kapitalforvaltning fully exited Celgene Corp in Q4 2019, selling an estimated $17.5M.
  • Xact Kapitalforvaltning's ten largest holdings make up 22% of its $5.88B portfolio in Q4 2019.
  • Xact Kapitalforvaltning opened 30 new positions and closed 51 in Q4 2019.
  • Xact Kapitalforvaltning's portfolio value rose 12% quarter-over-quarter to $5.88B.

Based on Xact Kapitalforvaltning's 13F filing for Q4 2019, filed 14 Feb 2020.